Potent Inhibition of Norovirus 3CL Protease by Peptidyl α-Ketoamides and α-Ketoheterocycles
Noroviruses belong to the Norovirus genus of the Caliciviridae family. 1 They are highly contagious human pathogens that have attracted considerable attention because they are the most common cause of foodborne and waterborne acute gastroenteritis. [2] [3] [4] [5] Outbreaks of acute gastroenteritis are common, particularly in crowded settings, such as schools, nursing homes, and cruise ships. There are currently no vaccines or specific antiviral agents for combating norovirus infection; 6 thus, there is an urgent and unmet need for the discovery and development of small-molecule anti-norovirus therapeutics.
Noroviruses are small, enveloped viruses with a single-stranded, positive sense 7.7-kb RNA genome, which encodes a polyprotein precursor which is co-and posttranslationally processed by a virus-encoded cysteine protease to generate mature nonstructural proteins. 7 Processing of the polyprotein by norovirus 3CL protease (3CLpro) is essential for virus replication; consequently, norovirus 3CLpro has emerged as an attractive target for the discovery of therapeutics for norovirus infection. 8 Norovirus 3CLpro is a cysteine endoprotease with a Cys-His-Glu catalytic triad and a substrate specificity for a -D/E-F-X-L-Q-G-P-sequence, where X is H, Q, E or D, corresponding to the subsites S 5 -S 4 -S 3 -S 2 -S 1 -S 1 '-S 2 '-. Cleavage is at the P 1 -P 1 ' (Q-G) scissile bond. X-ray crystal structures of norovirus 3CLpro alone 9-10 or covalently-bound to an inhibitor, such as a peptidyl Michael acceptor 11 or a peptidyl aldehyde, 12 have been reported.
We have recently described the cell-based inhibition of noroviruses by an array of structurally-diverse series of compounds [13] [14] [15] [16] [17] and have, furthermore, disclosed the results of preliminary studies related to the design, synthesis, and evaluation of peptidyl aldehydes as transition state inhibitors of norovirus 3CLpro. 8 In an attempt to identify suitably-functionalized dipeptidyl inhibitors that possess pharmacological activity and molecular properties that are important for oral bioavailability and favorable ADMET characteristics, [18] [19] [20] [21] [22] [23] [24] we describe herein the synthesis and utilization of a series of peptidyl α-ketoamides and α-ketoheterocycles ( Figure 1 , structures I-II) in the in vitro inhibition of norovirus 3CLpro, as well as the inhibition of norovirus using a cell-based replicon system. The synthesized compounds were also used to probe the S' subsites of the enzyme.
[ Figure 1 ]
The syntheses of α-ketoamides 6a-h and α-ketoheterocycles 8a-b (Table 1) were carried out as illustrated in Schemes 1 and 2, respectively. 25 A glutamine surrogate,
[ Table 1 ]
previously shown to be highly effective in the design of rhinovirus 3C 26 and enterovirus 3C 27 proteases, was utilized as the primary specificity (P 1 ) residue. The Boc-protected surrogate was synthesized using literature procedures 28 and was subsequently deprotected to yield compound 1 (Scheme 1). EDCI-mediated coupling with Z-(L)-Leu-OH or Z-(L)-Phe-OH yielded compounds 2a-b which were reduced to the corresponding alcohols using lithium borohydride. Dess-Martin oxidation furnished aldehydes 4a-b which were reacted with an array of structurally-diverse isonitriles to generate a series of precursor alcohols 5a-g and 5h which, upon oxidation, yielded the desired α-ketoamides 6a-h. 29 α-Ketoheterocycle 8a was synthesized by sequentially treating a solution of oxazole in THF with borane and n-butyl lithium, 30 followed by reaction with aldehyde 4a, to yield precursor alcohol 7a which was subsequently oxidized to form α-ketoheterocycle 8a. Reaction of compound 4a with the anion generated by reacting thiazole with n-butyl lithium, 31 followed by Dess-Martin oxidation of the isolated precursor alcohol, yielded α-ketoheterocycle 2 (Scheme 2). The interaction of the generated precursors and final compounds with norovirus 3CLpro was investigated in vitro as previously described. 8 The activity of the generated compounds against norovirus was also investigated in a cell-based system [32] [33] [34] [35] and the combined results are summarized in Table 1 .
We have recently demonstrated that peptidyl aldehydes function as transition state inhibitors of NV 3CLpro. 8 In this report we demonstrate that α-ketoamides and α-ketoheterocycles inhibit norovirus 3CLpro in vitro, and also exhibit potent anti-norovirus activity in a cell-based system. S'-P' interactions have been previously utilized to increase the affinity and selectivity of inhibitors, including transition state analogs; 30, [36] [37] consequently, the S' subsites of norovirus 3CLpro were probed using a series of structurally-diverse α-ketoamides.
It is evident from the results summarized in Table 1 that peptidyl α-ketoamides (compounds 6a-g) potently inhibit norovirus 3CLpro in vitro. Most importantly, the compounds exhibit potent anti-norovirus activity in a cell-based replicon system. In order to enhance further the pharmacological activity of the compounds by exploiting favorable binding interactions between the R group in (I) (assumed to be projecting toward the S' subsites) and the enzyme, the nature of the R group was varied. Although the precise orientation of the R group will have to await the determination of the X-ray crystal structure of a ligand-enzyme complex (in progress), the results indicate that a wide range of R groups can be tolerated. As anticipated, the corresponding precursor alcohols (compounds 5a-h, Table 1 ) were substantially less active (vide infra).
Furthermore, replacement of P2 Leu with Phe decreased potency 4-fold (compare compounds 6a and 6h, Table 1 ), a finding that is consistent with the strong preference of the enzyme for a Leu residue at P 2 . Intriguingly, precursor alcohols 5a, 5h and 7b exhibited noteworthy activity in the cell-based replicon system despite their weak in vitro inhibitory activity against norovirus 3CLpro.
In order to computationally predict binding modes for compounds 6a and 6h, a receptor structure for norovirus 3CLpro was prepared using the reported crystal structure 11 by extracting the co-crystallized covalently-bound peptidyl ligand and all resolved water. 38 The Figure   2 ), which tends to shift the 6h binding mode outwards, disrupting the ligand H-bond with Gln110.
α-Ketoheterocycles 8a-b were also found to inhibit norovirus 3CLpro in vitro, with the oxazole derivative being about 4-fold more potent than the corresponding thiazole compound ( Table 1 ). Both compounds were found to inhibit norovirus in a cell-based replicon system, with isoxazole 8a being the most effective (ED 50 900 nM).
In summary, a series of structurally-diverse α-ketoamides and α-ketoheterocycles has been synthesized and shown to potently inhibit norovirus 3CLpro in vitro, as well as norovirus in a cell-based replicon system. added to the remaining structure using SYBYL 39 and the covalently-bound ligands (compounds 6a and 6h) were assembled sequentially as follows:
beginning with the bare sulfur on Cys 139 left from deletion of the co-crystallized ligand, SYBYL was used to add the nearest ligand heavy atom, protons were added to the resulting complex, and then the ligand position was optimized using 
